Come to think of it, his actual deals have boded well for shareholders, compared to Stoll (omitting the timing, and length of time, to close) . The amounts, no, but the terms and types of deals, yes. The problem is that nobody knows Varney. Stoll f*k'd this stock up so much, Varney can't get out of his pitch black, massive shadow. Corx & Varney are under the radar, which is a good thing, when it comes to boneheaded remarks, like predicting the signing of a deal in 6 weeks; and boneheaded decisions, like giving yourself a bonus for slaughtering the shareprice and selling the meat well below cost (that hugely positive deal--except for the share price--signed with Biovail)...
Given everything, he should now deal with the reality that it is time to go, along with Stoll, and the effortless BOD to boot. It will take real money to do it--a pharma will skin us and use our derma to blanket the executives and board. I hate to suggest it, but real snakes like R&R, JMP, Renaissance etc. are our best bet...
Relinquish control, leave with dignity, and pray for Cortex. Amen
Market Data 
Markets 
AI
